ストックスクリーナーアプリを入手
181.47
3.86%
-7.29
プレマーケット:
181.48
0.010
+0.01%
前日終値:
$188.76
開ける：
$189.88
24時間の取引高:
314.38K
Relative Volume:
0.91
時価総額：
$5.25B
収益：
$290.51M
当期純損益:
$89.16M
株価収益率:
60.69
EPS:
2.99
ネットキャッシュフロー:
$119.18M
1週間 パフォーマンス:
-1.03%
1か月 パフォーマンス:
+32.02%
6か月 パフォーマンス:
+12.96%
1年 パフォーマンス:
+4.81%
1日の値動き範囲:
$181.32
$190.01
1週間の範囲:
$179.80
$190.01
52週間の値動き範囲:
$122.80
$207.84
Krystal Biotech Inc Stock (KRYS) Company Profile
名前
Krystal Biotech Inc
セクター
電話
(412) 586-5830
住所
2100 WHARTON STREET, PITTSBURGH, PA
KRYS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
181.47 | 5.46B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-05 | 開始されました | Jefferies | Buy |
| 2024-08-06 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-11-20 | 開始されました | Goldman | Buy |
| 2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-10-12 | 開始されました | Citigroup | Buy |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-18 | 開始されました | Stifel | Buy |
| 2023-02-28 | アップグレード | Goldman | Neutral → Buy |
| 2022-08-25 | ダウングレード | Goldman | Buy → Neutral |
| 2022-01-18 | 開始されました | BofA Securities | Buy |
| 2021-07-20 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-18 | 開始されました | B. Riley FBR | Buy |
| 2020-06-04 | 開始されました | Evercore ISI | Outperform |
| 2019-09-24 | 開始されました | Goldman | Neutral |
| 2019-08-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-06-24 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-06-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-05-30 | 開始されました | Guggenheim | Buy |
| 2018-09-11 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Krystal Biotech Inc (KRYS) 最新ニュース
Is Krystal Biotech Inc. meeting your algorithmic filter criteriaIndex Update & Weekly Stock Performance Updates - newser.com
Krystal Biotech Inc. stock outlook for YEARJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Will Krystal Biotech Inc. (4KB) stock outperform Dow Jones2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
What machine learning models say about Krystal Biotech Inc.2025 Support & Resistance & Short-Term High Return Ideas - newser.com
Is Krystal Biotech Inc 4KB a good long term investmentCandlestick Trading Patterns & Budget Investment Success - earlytimes.in
I See Some Speculative Wins Starting to Krystal-ize - TheStreet Pro
What high frequency data says about Krystal Biotech Inc.2025 Momentum Check & Fast Gain Stock Tips - newser.com
Published on: 2025-10-10 04:55:37 - newser.com
Market Participants Recognise Krystal Biotech, Inc.'s (NASDAQ:KRYS) Earnings Pushing Shares 29% Higher - simplywall.st
Sentiment analysis tools applied to Krystal Biotech Inc.Trade Exit Report & Technical Entry and Exit Alerts - newser.com
How Krystal Biotech Inc. stock reacts to Fed rate cutsCEO Change & AI Forecasted Entry/Exit Points - newser.com
Is Krystal Biotech Inc. (4KB) stock a buy for dividend portfoliosTrade Performance Summary & Growth Focused Stock Pick Reports - newser.com
How Krystal Biotech Inc. (4KB) stock reacts to monetary easingTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Will Krystal Biotech Inc. (4KB) stock see valuation expansionTrend Reversal & Safe Capital Growth Trade Ideas - newser.com
What’s the recovery path for long term holders of Krystal Biotech Inc.Weekly Trading Summary & Community Verified Trade Signals - newser.com
Is Krystal Biotech Inc. (4KB) stock worth buying before Fed action2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Krystal Biotech Hits Day High with 9.54% Surge in Strong Performance - Markets Mojo
Signal strength of Krystal Biotech Inc. stock in tech scannersJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com
Applying Elliott Wave Theory to Krystal Biotech Inc.Trade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Analyzing drawdowns of Krystal Biotech Inc. with statistical toolsSell Signal & Weekly Return Optimization Alerts - newser.com
Exploring 3 High Growth Tech Stocks in the US Market - Yahoo Finance
Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor? - MSN
Krystal Biotech Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner - Sahm
Tealwood Asset Management Inc. Invests $1.13 Million in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech, Inc. (KRYS) Stock Analysis: Uncovering a 22% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews
Krystal Biotech, Inc. (KRYS) Stock Analysis: A Potential 22% Upside with Strong Buy Ratings - DirectorsTalk Interviews
Tempus Wealth Planning LLC Takes Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Should You Invest in BLS Infotech Limited Before Its Next Earnings ReportPrice-to-Earnings Ratio Insights & High Yield Portfolio Growth - earlytimes.in
Krystal Biotech Inc (KRYS) 財務データ
収益
当期純利益
現金流量
EPS
Krystal Biotech Inc (KRYS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Krishnan Suma | President, R&D |
Jul 14 '25 |
Sale |
150.30 |
13,400 |
2,014,015 |
1,512,529 |
| Krishnan Suma | President, R&D |
Jul 15 '25 |
Sale |
151.01 |
3,084 |
465,700 |
1,509,445 |
| Krishnan Suma | President, R&D |
Jul 15 '25 |
Sale |
150.98 |
3,036 |
458,361 |
1,440,240 |
| Krishnan Suma | President, R&D |
Jul 16 '25 |
Sale |
150.00 |
1,529 |
229,350 |
1,438,711 |
| Krishnan Suma | President, R&D |
Jul 16 '25 |
Sale |
150.00 |
1,389 |
208,350 |
1,508,056 |
| Krishnan Krish S | President and CEO |
Jul 14 '25 |
Sale |
150.30 |
13,435 |
2,019,225 |
1,443,276 |
| Krishnan Krish S | President and CEO |
Jul 14 '25 |
Sale |
150.30 |
13,400 |
2,014,015 |
1,512,529 |
| Krishnan Krish S | President and CEO |
Jul 15 '25 |
Sale |
151.01 |
3,084 |
465,700 |
1,509,445 |
| Krishnan Krish S | President and CEO |
Jul 15 '25 |
Sale |
150.98 |
3,036 |
458,361 |
1,440,240 |
| Krishnan Krish S | President and CEO |
Jul 16 '25 |
Sale |
150.00 |
1,529 |
229,350 |
1,438,711 |
5.74%
大文字化:
|
ボリューム (24 時間):